INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo REDUVIT CAPSULES

SCHEDULING STATUS:
Not scheduled.

PROPRIETARY NAME
(and dosage form):

REDUVIT CAPSULES

COMPOSITION:Each capsule contains:
Vitamin A 5000 i.u
Vitamin B1 2.0 mg
Vitamin B2 2.0 mg
Vitamin B6 2.5 mg
Vitamin B12 2.0 micrograms
Nicotinamide 25.0 mg
Vitamin C 65.0 mg
Vitamin D 400 i.u.
Calcium Pantothenate 10.0 mg
Folic Acid 0.5 mg
Ferrous Fumarate 54.6 mg
Magnesium 65.0 mg
Zinc 20.0 mg
Iodine 225.0 micrograms
Potassium 70.0 micrograms
Phosphate 20.0 mg
Manganese 0.1 mg
Molybdenum 0.02 mg
Calcium 40.0 mg

PHARMACOLOGICAL CLASSIFICATION:
A 22.1.4 Vitamins: Other.

INDICATIONS:
Reduvit capsules are indicated as a dietary supplement where a deficiency of the relevant vitamins or minerals exists.

CONTRA-INDICATIONS:
Reduvit capsules are contra-indicated in any persons who are hypersensitive to any of the ingredients.
They should not be given to persons suffering from pulmonary tuberculosis.

WARNINGS:
Safety in pregnancy and lactation has not been established.
WARNING: Women who are, or who might become pregnant should avoid taking daily supplements containing more than 5000 i.u. VITAMIN A, without consulting a medical practitioner.
Safe dosage may be exceeded when medicines and/or health products containing Vitamin A are taken together with a high dietary intake of Vitamin A.

DOSAGE AND DIRECTIONS FOR USE:
Adults:One capsule a day unless otherwise recommended by a doctor.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Hypersensitivity to one or more of the ingredients may be encountered. Discontinue use of product immediately if hypersensitivity reaction occurs. Large doses of Vitamin B2 may result in a bright yellow discolouration of the urine, which may interfere with certain laboratory tests. Large doses of Vitamin C may cause diarrhea or other gastrointestinal disturbances and the formation of kidney stones. Caution should be taken when administering Vitamin C to patients with hyperoxaluria. Hypervitaminosis A may occur (See following section).
The iron in ferrous fumarate may cause gastric irritation, with either constipation or diarrhea, and nausea and vomiting. Taking the medication either with or after food can reduce these side effects. The absorption of iron is reduced in the presence of some antacids and tea. The absorption of iron and tetracyclines is reduced when they are taken concomitantly by mouth. Iron may reduce the effect of certain other drugs such as penicilamine, levadopa, methyldopa and fluoroquinolone such as ciprofloxacin.
Vitamin D should not be administered to patients with hypercalcaemia. The effects of Vitamin D may be reduced in patients taking barbiturates and other anticonvulsants.
Calcium should not be given together with phenytoin or tetracyclines as decreased absorption of these drugs will result.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Enhanced susceptibility to the effects of Vitamin A may be seen in children and in patients with liver disease. Hypervitaminosis A is caused by the administration of excessive amounts of Vitamin A over long periods. It is characterized by fatigue, irritability, anorexia and loss of weight, vomiting and other gastrointestinal disturbances, low grade fever, enlargement of the liver and spleen, loss of hair, cracked and bleeding lips, dry, itching, peeling of skin, horny growths on the skin and yellow pigmentation. Anaemia, headache, tinnitus, visual disturbances, subcutaneous swelling, pains in bones and joints and tenderness over the long bones may occur. Pappiloedema and raised intracranial pressure mimicking brain tumors have been reported. Symptoms usually clear on the withdrawal of the Vitamin A, but in children bone growth may be arrested.
Acute Vitamin A intoxication may occur with very high doses, and is characterized by sedation, headache, irritability, papilleodema and generalized peeling of the skin.
Symptoms of excessive Vitamin D intake are anorexia, muscle weakness, vertigo, nausea and vomiting, diarrhea, weight loss, profuse sweating, headache, extreme thrist, production of a large volume of urine in a given period, proteinuria and bone pain. The calcium and phosphorous concentrations in the serum and urine are increased which may lead to hypertension, renal failure and cardiac arrhythmias. The plasma cholesterol concentration may also be increased.
In the event of overdose, medical assistance should be sought immediately. Treatment is symptomatic and supportive.

IDENTIFICATION:
Wine red coloured capsules.

PRESENTATION:
30 Capsules blister packed and placed into a carton.

STORAGE INSTRUCTIONS:
Keep in a cool place, below 25°C, protected from light. KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
T1192 (Wet/Act 101/1965)

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
TECHNIKON LABORATORIES (PTY) LTD
1073 Anvil Road, Robertville, Florida. Tel: (011) 674-1091

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
2 September 1985

New addition to this site: February 2007
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2006